Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fotemustine in recurrent or progressive glioblastoma multiforme
2004-001664-50Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fotemustine in glioblastoma (GBM), sponsored by Italfarmaco. Started Jun 2005; status: completed.
02
Drugs
fotemustine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2004-001664-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001664-50.